New York-based private equity firm The Jordan Company is in advanced discussions to acquire DuPont de Nemours’ resins business in a deal valued at around $1.8bn, according to a report by Bloomberg.
The report cites unnamed sources with knowledge of the matter as suggesting that a deal could be agreed as early as this week, although no decision has yet been made and talks could still end without an agreement being reached.
Jordon is in pole position to acquire the business having seen off competition from rival private equity firms, including Lone Star Funds and Platinum Equity, according to previous Bloomberg reports.
Jordan, which focuses on the middle-market, has a history of investing in chemicals companies, having owned stakes in Arclin, Vantage and Polymer Solutions Group, according to its website.
